PB2621: TREATMENT OF IMMUNE THROMBOCYTOPENIA WITH HETROMBOPAG—A SINGLE-CENTER RETROSPECTIVE, OBSERVATIONAL STUDY
Main Authors: | Hu Zhou, Bingjie Ding, Liu Liu, Xuewen Song, Mengjuan LI, Yuanyuan Zhang, Xia Ao, Jingyuan Liu, Juanjuan Song, Yu Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000977172.75861.19 |
Similar Items
-
PB2606: REAL-WORLD EXPERIENCE OF HETROMBOPAG IN RELAPSE AND REFRACTORY IMMUNE THROMBOCYTOPENIA
by: Yimei Feng, et al.
Published: (2023-08-01) -
Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients
by: Bingjie Ding, et al.
Published: (2023-12-01) -
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
by: Heng Mei, et al.
Published: (2021-02-01) -
Treatment of immune thrombocytopenia with hetrombopag olamine tablets in a Kabuki syndrome patient with new KMT2D mutations
by: Peng Peng, et al.
Published: (2023-12-01) -
P1287: HETROMBOPAG FOR ENHANCEMENT OF PLATELET ENGRAFTMENT IN PATIENTS WITH LYMPHOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Linjun Zhao, et al.
Published: (2023-08-01)